{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:25:19Z","timestamp":1773915919804,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1016\/j.drup.2003.08.003","type":"journal-article","created":{"date-parts":[[2003,11,5]],"date-time":"2003-11-05T03:24:32Z","timestamp":1068002672000},"page":"257-269","source":"Crossref","is-referenced-by-count":51,"title":["Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far"],"prefix":"10.1016","volume":"6","author":[{"given":"Dimitrios P.","family":"Kontoyiannis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell E.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2003.08.003_BIB1","doi-asserted-by":"crossref","unstructured":"Antoniadou, A., Torres, H., Lewis, R.E., Raad, I.I., Thornby, J., Tarrand, J.J., Rolston, K., Safdar, A., Han, X., Bodey, G.P., Kontoyiannis, D.P., 2003. In vitro susceptibility of bloodstream candidiasis in cancer patients: correlation with outcome of antifungal therapy. Medicine 82 (5); 309\u2013321.","DOI":"10.1097\/01.md.0000091182.93122.8e"},{"key":"10.1016\/j.drup.2003.08.003_BIB2","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/cncr.11115","article-title":"Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin","volume":"97","author":"Aliff","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.drup.2003.08.003_BIB3","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1128\/AAC.45.3.922-926.2001","article-title":"Pharmacodynamcis of amphotericin B in a neutropenic mouse disseminated-candidiasis model","volume":"45","author":"Andes","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2003.08.003_BIB4","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/AAC.44.9.2435-2441.2000","article-title":"Interactions between triazoles and amphotericin B against Cryptococcus neoformans","volume":"44","author":"Barchiesi","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2003.08.003_BIB5","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1056\/NEJM197907193010303","article-title":"A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis","volume":"301","author":"Bennett","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2003.08.003_BIB6","unstructured":"Boktour, M.R., Kontoyiannis, D.P., Hanna, H.A., Hachem, R.Y., Girgawy, E., Bodey, G.P., Raad, I.I., 2003. Multiple-species candidemia in cancer patients. In: 41st Infectious Diseases Society of America (IDSA) meeting, San Diego, CA (abstract # 1254)."},{"key":"10.1016\/j.drup.2003.08.003_BIB7","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1128\/AAC.46.9.3001-3012.2002","article-title":"The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro","volume":"46","author":"Bowman","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2003.08.003_BIB8","unstructured":"Capilla Luqeue, J., Clemons, K.V., Stevens, D.A., 2001. Program and Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL."},{"key":"10.1016\/j.drup.2003.08.003_BIB9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/AAC.33.3.362","article-title":"Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholate","volume":"33","author":"Collette","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2003.08.003_BIB10","doi-asserted-by":"crossref","unstructured":"Cozens, R.M., 1999. Formulation of compounds and determination of pharmacokinetic parameters. In: S.M.A., Zak, Otto. (Eds.), Handbook of Animal Models of Infection. Academic Press, San Diego, CA.","DOI":"10.1016\/B978-012775390-4\/50149-4"},{"key":"10.1016\/j.drup.2003.08.003_BIB11","doi-asserted-by":"crossref","unstructured":"Cuenca-Estrella, M., Gomez-Lopez, A., Mellado, E., Buitrago, M.J., Monzon, A., Rodriguez-Tuleda, H.L., 2003, Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents. Antimicrob. Agents Chemother. 47, 2339\u20132341.","DOI":"10.1128\/AAC.47.7.2339-2341.2003"},{"key":"10.1016\/j.drup.2003.08.003_BIB12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00002030-199202000-00007","article-title":"Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis","volume":"6","author":"De Gans","year":"1992","journal-title":"AIDS"},{"key":"10.1016\/j.drup.2003.08.003_BIB13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/clinids\/23.3.608","article-title":"Therapeutic outcome in invasive aspergillosis","volume":"23","author":"Denning","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2003.08.003_BIB14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/clinids\/12.6.1147","article-title":"Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases","volume":"12","author":"Denning","year":"1990","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.drup.2003.08.003_BIB15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1128\/AAC.42.3.528","article-title":"Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis","volume":"42","author":"Diamond","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2003.08.003_BIB16","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1128\/AAC.41.7.1589","article-title":"Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis","volume":"41","author":"Ding","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2003.08.003_BIB17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/520192","article-title":"Nosocomial bloodstream infections in United States hospitals: a three-year analysis","volume":"29","author":"Edmond","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2003.08.003_BIB18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1086\/514504","article-title":"International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections","volume":"25","author":"Edwards","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2003.08.003_BIB19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0891-5520(20)30277-4","article-title":"Synergism and antagonism","volume":"3","author":"Eliopoulos","year":"1989","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.drup.2003.08.003_BIB20","unstructured":"Eliopoulos, G.M., Moellering, R.C., 1996. Antimicrobial combinations. In: Lorain, V. (Ed.), Antibiotics and Laboratory Medicine, 4th ed. Williams and Wilkins, Baltimore."},{"key":"10.1016\/j.drup.2003.08.003_BIB21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0732-8893(98)00130-8","article-title":"In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods","volume":"33","author":"Ernst","year":"1999","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.drup.2003.08.003_BIB22","unstructured":"Flattery, A.J., Bartizol, K., Gill, C.J., Kong, L., Leighton, C., Pikounis, V.B., Rosen, H., Smith, J.G., Aruzzo, G.K., 1998. Preclinical efficacy of MK-0991 in combination with amphotericin B or fluconazole in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. In: Program and Abstracts for the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA (abstract J-61)."},{"key":"10.1016\/j.drup.2003.08.003_BIB23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/infdis\/168.3.692","article-title":"Combination therapy in experimental invasive aspergillosis","volume":"168","author":"George","year":"1993","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drup.2003.08.003_BIB24","first-page":"331","article-title":"The search for synergy: a critical review from a response surface perspective","volume":"47","author":"Greco","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.drup.2003.08.003_BIB25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1054-3589(08)60129-5","article-title":"Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development","volume":"44","author":"Groll","year":"1998","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.drup.2003.08.003_BIB26","unstructured":"Hachem, R., Afif, C., Cooksley, C., Boktour, M., Chatzinikolaou, I., Kahn, A., Saah, A., Kontoyiannis, D., Rolston, K., Raad, I., 2000. Invasive aspergillosis in cancer patients: poor outcome despite aggressive therapy. In: Program and Abstracts of the American Society of Hematology, San Francisco, CA."},{"key":"10.1016\/j.drup.2003.08.003_BIB27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.6.1.1","article-title":"Compounds active against cell walls of medically important fungi","volume":"6","author":"Hector","year":"1993","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.drup.2003.08.003_BIB28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10096-002-0877-z","article-title":"Succesful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine","volume":"22","author":"Howden","year":"2003","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.drup.2003.08.003_BIB29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/jac\/18.1.65","article-title":"Ketoconazole and flucytosine alone and in combination against Candida spp. in a neutropenic site in rabbits","volume":"18","author":"Hughes","year":"1986","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drup.2003.08.003_BIB30","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/infdis\/173.5.1216","article-title":"Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome","volume":"173","author":"Kartalija","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drup.2003.08.003_BIB31","unstructured":"Kirkpatrick, W.R., Mcatee, R.K., Ryder, N.S., Patterson, T.F., 1998. Programs and Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA (abstract J-77)."},{"key":"10.1016\/j.drup.2003.08.003_BIB32","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1128\/AAC.46.8.2564-2568.2002","article-title":"Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis","volume":"46","author":"Kirkpatrick","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2003.08.003_BIB33","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1128\/AAC.41.6.1392","article-title":"Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans","volume":"41","author":"Klepser","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2003.08.003_BIB34","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1128\/AAC.44.7.1917-1920.2000","article-title":"Evaluation of voriconazole pharmacodynamics using time-kill methodology","volume":"44","author":"Klepser","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2003.08.003_BIB35","doi-asserted-by":"crossref","unstructured":"Kohno, S., Maesaki, S., Iwakawa, J., Miyazaki, Y., Nakamura, K., Kakeya, H., Yanigihara, K., Ohno, H., Higashiyama, Y., Tashiro, T., 2000. Presented at the Program and Abstract of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (abstract J-1686).","DOI":"10.1007\/PL00012145"},{"key":"10.1016\/j.drup.2003.08.003_BIB36","doi-asserted-by":"crossref","first-page":"175S","DOI":"10.1592\/phco.21.12.175S.34506","article-title":"A clinical perspective for the management of invasive fungal infections: focus on IDSA guidelines","volume":"21","author":"Kontoyiannis","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.drup.2003.08.003_BIB37","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0140-6736(02)08162-X","article-title":"Antifungal drug resistance of pathogenic fungi","volume":"359","author":"Kontoyiannis","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2003.08.003_BIB38","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1128\/AAC.44.10.2915-2918.2000","article-title":"Itraconazole-amphotericin B antagonism in Aspergillus fumigatus: an E-test-based strategy","volume":"44","author":"Kontoyiannis","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2003.08.003_BIB39","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cncr.11479","article-title":"Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatement in invasive aspergillosis in patients with hematological malignancies","volume":"98","author":"Kontoyiannis","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.drup.2003.08.003_BIB40","doi-asserted-by":"crossref","unstructured":"Kontoyiannis, D., Bodey, G., Hanna, H., Hachem, R., Boktour, M., Girgaway, E., Mardani, M., Raad, I.I., 2003b. Outcome determinants if fusariosis in a tertiary care cancer center: the impact of neutrophil recovery. Leuk. Lymphoma, in press.","DOI":"10.1080\/1042819031000149386"},{"key":"10.1016\/j.drup.2003.08.003_BIB41","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/AAC.46.6.1773-1780.2002","article-title":"Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins","volume":"46","author":"Kuhn","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2003.08.003_BIB42","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1128\/AAC.38.7.1480","article-title":"Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-d-glucan synthase","volume":"38","author":"Kurtz","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2003.08.003_BIB43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7326\/0003-4819-113-3-183","article-title":"Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial","volume":"113","author":"Larsen","year":"1990","journal-title":"Ann. Int. Med."},{"key":"10.1016\/j.drup.2003.08.003_BIB44","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/clinids\/19.4.741","article-title":"Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS","volume":"19","author":"Larsen","year":"1994","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.drup.2003.08.003_BIB45","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1128\/CMR.12.2.310","article-title":"Aspergillus fumigatus and aspergillosis","volume":"12","author":"Latge","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.drup.2003.08.003_BIB46","doi-asserted-by":"crossref","first-page":"149S","DOI":"10.1592\/phco.21.12.149S.34505","article-title":"Rationale for combination antifungal therapy","volume":"21","author":"Lewis","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.drup.2003.08.003_BIB47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1300\/J100v03n04_04","article-title":"Combination systemic antifungal therapy for cryptococosis, candidiasis, and aspergillosis","volume":"3","author":"Lewis","year":"1999","journal-title":"J. Infect. Dis. Pharm."},{"key":"10.1016\/j.drup.2003.08.003_BIB48","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/jac\/49.2.345","article-title":"Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species","volume":"49","author":"Lewis","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drup.2003.08.003_BIB49","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2003.08.003_BIB50","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1128\/AAC.43.12.2841","article-title":"Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans","volume":"43","author":"Louie","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2003.08.003_BIB51","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1128\/AAC.45.2.485-494.2001","article-title":"Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis","volume":"45","author":"Louie","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2003.08.003_BIB52","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1128\/JCM.39.9.3402-3408.2001","article-title":"Colorimetric assay for antifungal susceptibility testing of Aspergillus species","volume":"39","author":"Meletiadis","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.drup.2003.08.003_BIB53","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1128\/JCM.39.12.4256-4263.2001","article-title":"Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species","volume":"39","author":"Meletiadis","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.drup.2003.08.003_BIB54","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2003.08.003_BIB55","unstructured":"Najvar, L., Hernendez, S., Bocenegra, R., Halpern, J., Gurnani, M., Menzel, F., Cacciapuoti, A., Lowenberg, D., Graybill, J.R., 2002. Programs and Abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (abstract M-1818)."},{"key":"10.1016\/j.drup.2003.08.003_BIB56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the checquerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1016\/j.drup.2003.08.003_BIB57","unstructured":"O\u2019Reilly, T., Cleeland, R., Squires, E.L., 1996. Evaluation of antimicrobials in experimental animal models. In: Zak, O., Sande, M. (Eds.), Handbook of Animal Models of Infection, 4th ed. Williams and Wilkins, Baltimore."},{"key":"10.1016\/j.drup.2003.08.003_BIB58","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005792-200007000-00006","article-title":"Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group","volume":"79","author":"Patterson","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.drup.2003.08.003_BIB59","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1086\/375420","article-title":"Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin","volume":"187","author":"Petraitis","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drup.2003.08.003_BIB60","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1128\/AAC.47.3.1068-1071.2003","article-title":"In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates","volume":"47","author":"Pfaller","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2003.08.003_BIB61","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000238524","article-title":"Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice","volume":"33","author":"Polak","year":"1987","journal-title":"Chemotherapy"},{"key":"10.1016\/j.drup.2003.08.003_BIB62","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1201-9712(99)90038-3","article-title":"Amphotericin B with and without itraconazole for invasive aspergillosis: a three-year retrospective study","volume":"3","author":"Popp","year":"1999","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.drup.2003.08.003_BIB63","unstructured":"Ratanatharathorn, V., Flynn, P., van Burik, J., McSweeney, P., Niederwieser, D., Kontoyiannis, D.P., 2002. Micafungin in combination with systemic antifungal agents in the treatment of refractory aspergillosis in bone marrow transplant patients. Programs and abstracts of the 44th Annual American Society of Hematology, Abstract 2472."},{"key":"10.1016\/j.drup.2003.08.003_BIB64","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1086\/313749","article-title":"Practice guidelines for the treatment of candidiasis","volume":"30","author":"Rex","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2003.08.003_BIB65","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/CMR.14.4.643-658.2001","article-title":"Antifungal susceptibility testing: practical aspects and current challenges","volume":"14","author":"Rex","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.drup.2003.08.003_BIB66","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/320876","article-title":"Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses","volume":"33","author":"Rex","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2003.08.003_BIB67","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/374850","article-title":"A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects","volume":"36","author":"Rex","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2003.08.003_BIB68","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1086\/339755","article-title":"Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans","volume":"34","author":"Rubin","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drup.2003.08.003_BIB69","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/infdis\/151.5.902","article-title":"The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis","volume":"151","author":"Schaffner","year":"1985","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drup.2003.08.003_BIB70","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1439-0507.1991.tb00660.x","article-title":"Combination therapy in a model of pulmonary aspergillosis","volume":"34","author":"Schmitt","year":"1991","journal-title":"Mycoses"},{"key":"10.1016\/j.drup.2003.08.003_BIB71","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1086\/515319","article-title":"Interactions of itraconazole with amphotericin B in the treatment of murine invasive candidiasis","volume":"177","author":"Sugar","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drup.2003.08.003_BIB72","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1128\/AAC.39.3.598","article-title":"Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B","volume":"39","author":"Sugar","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2003.08.003_BIB73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome","volume":"337","author":"van der Horst","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2003.08.003_BIB74","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF01739009","article-title":"Amphotericin B versus amphotericin B plus 5-flucytocine: poor results in the treatment of proven systemic mycoses in neutropenic patients","volume":"22","author":"Verweij","year":"1994","journal-title":"Infection"},{"key":"10.1016\/j.drup.2003.08.003_BIB75","unstructured":"Wiederhold, N.P., Kontoyiannis, D.P., Chi, J., Prince, R.A., Tam, V.H., Lewis, R.E., 2003. In vivo pharmacodynamics of caspofungin in a murine model of invasive aspergillosis. Programs and Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (abstract M-476)."},{"key":"10.1016\/j.drup.2003.08.003_BIB76","doi-asserted-by":"crossref","unstructured":"Working Party of the British Society for Antimicrobial Chemotherapy, 1993. Chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: a review and recommendations. J. Antimicrob. Chemother. 32, 5\u201321.","DOI":"10.1093\/jac\/32.1.5"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764603000852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764603000852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T16:49:34Z","timestamp":1623516574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764603000852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["S1368764603000852"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2003.08.003","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}